Tuberculosis
Isoniazid effective for latent tuberculosis infection
Published in Drug Week, October 10th, 2003
"Isoniazid is an efficacious treatment for latent tuberculosis. Concerns remain, however, regarding hepatotoxicity associated with this medication. In addition, adherence may be suboptimal because at least six months of treatment is required," scientists in the United States report.
"We extracted information from our latent tuberculosis treatment database to determine adverse effects and treatment completion rates associated with the use of isoniazid at a county tuberculosis clinic," stated Philip A. Lobue and Kathleen S. Moser at the Centers for Disease Control and Prevention....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2003-10-10)
More Articles from Drug Week
- Cancer Therapy
Sphingosine kinase inhibitors may hold key to halting growth of some tumors - Colon Cancer
Poloxamer-containing liposomes can be used for heat-sensitive drug delivery - Dementia
New class of drug helps people with severe dementia and their careers - Drug Development
Ubiquitin-like peptide with anticancer and immunostimulatory activity isolated from mushroom - Otitis Media
Augmentin ES-600T more effective than Zithromax in study - Ovarian Cancer
Paclitaxel temporarily adds to the sensory neurotoxicity of cisplatin - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
